Defilade Capital Management »

Nuvalent Inc-a shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Nuvalent Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $13M 130k 102.45

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Nuvalent Inc-a

Deerfield Management Company
FMR
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
RA Capital Management
Vanguard Portfolio Management
Wellington Management Company
Vanguard Capital Management
State Street Corporation
Perceptive Advisors
Polar Capital Holdings
Deep Track Capital
T. Rowe Price Investment Management
Geode Capital Management

View all funds holding Nuvalent Inc-a